| 1 | FCRL1 levels | GCST90469205 | 134.55 |
| 2 | Multiple myeloma or monoclonal gammopathy of undetermined significance | GCST90624746 | 131.51 |
| 3 | TCL1A levels | GCST90470817 | 129.29 |
| 4 | PARP1/TCL1A ratio | GCST90315602 | 126.13 |
| 5 | FCRL2 levels | GCST90469206 | 121.46 |
| 6 | CD22 levels | GCST90468610 | 121.06 |
| 7 | CD27/TNFRSF13B ratio | GCST90313777 | 119.39 |
| 8 | FCRL5/LY96 ratio | GCST90314803 | 117.46 |
| 9 | Lymphoid neoplasms (P-cell phenocluster) | GCST90624737 | 115.05 |
| 10 | FCER2 levels | GCST90469199 | 112.65 |
| 11 | SLAMF1 levels | GCST90274835 | 110.13 |
| 12 | Incidence of bisecting GlcNAc in all fucosylated disialylated structures (GP57) | GCST90668735 | 109.19 |
| 13 | FCER2/TREML2 ratio | GCST90314792 | 106.45 |
| 14 | Systemic lupus erythematosus | GCST90011866 | 100.66 |
| 15 | TNFRSF13B/TNFSF13B ratio | GCST90315933 | 93.26 |
| 16 | TNFSF13B levels | GCST90470920 | 91.96 |
| 17 | CD72 levels | GCST90468646 | 90.45 |
| 18 | IL5RA levels | GCST90469600 | 88.35 |
| 19 | Multiple myeloma | GCST90624747 | 88.26 |
| 20 | FCER2/FCRL1 ratio | GCST90314789 | 87.75 |
| 21 | TCL1A/TNFRSF13C ratio | GCST90315912 | 87.33 |
| 22 | JCHAIN levels | GCST90469661 | 80.39 |
| 23 | Non-albumin protein levels | UKBB00000503 | 77.37 |
| 24 | TNFRSF13C levels | GCST90470906 | 75.53 |
| 25 | CD27/TNFRSF9 ratio | GCST90313778 | 75.18 |
| 26 | TNFRSF13B levels | GCST90470905 | 74.66 |
| 27 | Pain in limb | FING00001138 | 73.58 |
| 28 | FCRL5/TNFRSF13B ratio | GCST90314805 | 73.56 |
| 29 | Disorders of plasma protein metabolism (PheCode 270.3) | GCST90475709 | 71.56 |
| 30 | Paraproteinemia (PheCode 270.32) | GCST90475710 | 70.41 |
| 31 | CD22/TCL1A ratio | GCST90313760 | 68.61 |
| 32 | FCER2/TNFRSF9 ratio | GCST90314791 | 66.90 |
| 33 | FCER2/TCL1A ratio | GCST90314790 | 65.67 |
| 34 | CR2/TNFRSF13B ratio | GCST90314225 | 63.65 |
| 35 | ALB/Globulin ratio | UKBB00000020 | 63.41 |
| 36 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 4) | GCST90320823 | 63.13 |
| 37 | FCRL1/TREML2 ratio | GCST90314797 | 63.00 |
| 38 | Bifidobacterium kashiwanohense abundance in stool | GCST90032226 | 62.29 |
| 39 | Physical activity (confirmatory factor analysis Factor 23) | GCST90309357 | 61.35 |
| 40 | Monoclonal gammopathy of undetermined significance | GCST90624745 | 60.01 |
| 41 | LILRB1 levels | GCST90469776 | 59.47 |
| 42 | FCRL1/TCL1A ratio | GCST90314795 | 59.10 |
| 43 | INPP5J levels | GCST90469618 | 57.70 |
| 44 | TNFRSF17 levels | GCST90470908 | 56.57 |
| 45 | IL18RAP levels | GCST90469566 | 55.54 |
| 46 | CD22/SEMA7A ratio | GCST90313759 | 55.33 |
| 47 | CR2 levels | GCST90468852 | 54.43 |
| 48 | Other soft tissue disorders, not elsewhere classified | FING00001099 | 54.25 |
| 49 | Lymphoid neoplasms (somatic mutation group 2 phenocluster) | GCST90624750 | 54.11 |
| 50 | FCRL1/TNFRSF13C ratio | GCST90314796 | 53.71 |
| 51 | Lymphocyte count | GCST004627 | 53.21 |
| 52 | Pre-existing hypertension complicating pregnancy, childbirth and the puerperium | FING00001203 | 51.17 |
| 53 | TNFRSF13B/TNFRSF9 ratio | GCST90315932 | 50.48 |
| 54 | CD5L levels | GCST90468640 | 50.33 |
| 55 | Idiopathic pulmonary fibrosis | FING00000659 | 49.00 |
| 56 | CRYBB2 levels | GCST90468875 | 47.09 |
| 57 | ZNRD2 levels | GCST90471103 | 46.67 |
| 58 | N-delta-acetylornithine levels | GCST90200691 | 45.92 |
| 59 | Lymphocyte count | Blood count | UKBB00000411 | 45.84 |
| 60 | PLXNA4/USP8 ratio | GCST90315690 | 45.76 |
| 61 | CD79B/TNFRSF13B ratio | GCST90313902 | 45.29 |
| 62 | Principal component-derived dietary pattern 42 | GCST90133047 | 45.11 |
| 63 | Blood cell traits latent factor 17 (white cell) | GCST90559259 | 44.52 |
| 64 | Percentage of fucosylation of monogalactosylated structures in total neutral plasma glycans (GP74) | GCST90668518 | 44.04 |
| 65 | MYCT1 levels | GCST90618046 | 43.36 |
| 66 | PEAR1/TREML2 ratio | GCST90315645 | 43.11 |
| 67 | Lymphoid neoplasms (B-cell phenocluster) | GCST90624736 | 43.07 |
| 68 | T1 FreeSurfer DKT rh insula area | GCST90384317 | 42.52 |
| 69 | FCRL2/TNFRSF13B ratio | GCST90314801 | 42.06 |
| 70 | Lymphoid neoplasms (drug group 1 phenocluster) | GCST90624740 | 41.64 |
| 71 | Lymphocyte count | GCST90002388 | 41.60 |
| 72 | Urine X-24796 levels in chronic kidney disease | GCST90266800 | 41.26 |
| 73 | wg rh intensity-contrast lingual | GCST90003839 | 41.02 |
| 74 | Colitis, primary sclerosing, strict definition | FING00000313 | 40.69 |
| 75 | NINJ1 levels | GCST90470049 | 40.54 |
| 76 | UGDH levels | GCST90471006 | 40.47 |
| 77 | Systemic lupus erythematosus | GCST90014238 | 40.26 |
| 78 | CD27/NBL1 ratio | GCST90313774 | 40.18 |
| 79 | BLNK levels | GCST90468448 | 40.17 |
| 80 | TXNDC15 levels | GCST90470990 | 39.98 |
| 81 | Lymphocyte count (UKB data field 30120) | GCST90468082 | 39.68 |
| 82 | CD22/FCRL1 ratio | GCST90313757 | 39.61 |
| 83 | GART levels | GCST90469303 | 39.45 |
| 84 | MBL2 levels | GCST90469868 | 39.38 |
| 85 | TRAF3 levels | GCST90470957 | 38.83 |
| 86 | FOLR2 levels | GCST90469260 | 38.65 |
| 87 | ThalamNuclei rh volume MGN | GCST90002737 | 38.08 |
| 88 | Occupational attainment | GCST90102253 | 37.95 |
| 89 | Cereal type - Other (e.g. Cornflakes, Frosties) | Diet | UKBB00000125 | 37.87 |
| 90 | MZB1/TNFRSF13B ratio | GCST90315509 | 37.46 |
| 91 | T1 CAT volume L LeftAccumbens | GCST90384108 | 37.03 |
| 92 | Time spend outdoors in summer | Sun exposure | UKBB00000817 | 36.92 |
| 93 | CD79B/TNFRSF4 ratio | GCST90313903 | 36.77 |
| 94 | IL5RA/TNFRSF13B ratio | GCST90315164 | 36.71 |
| 95 | IL2RA levels | GCST90469585 | 36.28 |
| 96 | CALCOCO1/MAP3K5 ratio | GCST90313605 | 36.27 |
| 97 | Lymphocyte count | GCST90002316 | 36.05 |
| 98 | CD22/FCER2 ratio | GCST90313756 | 35.84 |
| 99 | CD22/FOLR2 ratio | GCST90313758 | 35.83 |
| 100 | Depression | FING00000398 | 35.69 |
| 101 | Moderate to vigorous physical activity duration | GCST90061422 | 35.50 |
| 102 | FCGR2A levels | GCST90469200 | 35.32 |
| 103 | Cough on most days | Medical information | UKBB00000153 | 34.69 |
| 104 | PDCD1/TNFRSF8 ratio | GCST90315610 | 34.41 |
| 105 | Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders (more control exclusions) | FING00000101 | 34.31 |
| 106 | F-meat liking (derived food-liking factor) | GCST90094799 | 34.15 |
| 107 | Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61) | GCST90668505 | 33.86 |
| 108 | SEPTIN3 levels | GCST90470576 | 33.83 |
| 109 | Chronic lymphocytic leukemia | GCST90624738 | 33.77 |
| 110 | CD79B/CKAP4 ratio | GCST90313898 | 33.72 |
| 111 | Cereal type: Other (e.g. Cornflakes, Frosties) (UKB data field 1468_5) | GCST90132973 | 33.64 |
| 112 | Mood [affective] disorders | FING00000836 | 33.54 |
| 113 | THY1 levels | GCST90470861 | 33.38 |
| 114 | CD27 levels | GCST90468615 | 33.22 |
| 115 | Lymphocyte count | GCST90002317 | 32.90 |
| 116 | Sicca syndrome [Sjögren] | FING00001304 | 32.42 |
| 117 | TP53BP1 levels | GCST90470936 | 32.30 |
| 118 | Personal history of allergy to drugs, medicaments and biologocal substances | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000641 | 31.86 |
| 119 | Urticaria | FING00001408 | 31.58 |
| 120 | Primary biliary cholangitis | GCST90061440 | 31.27 |
| 121 | Right-hemisphere somatomotor network to amygdala white-matter structural connectivity | GCST90302799 | 31.07 |
| 122 | IL16 levels | GCST90469557 | 30.96 |
| 123 | wg rh intensity-contrast cuneus | GCST90003831 | 30.89 |
| 124 | Bread type - White | Diet | UKBB00000106 | 30.75 |
| 125 | ATP5IF1/LYN ratio | GCST90313389 | 30.34 |
| 126 | FCRL2/LY9 ratio | GCST90314799 | 30.24 |
| 127 | Beetroot liking | GCST90094702 | 30.03 |
| 128 | LRRC37A2 levels | GCST90469802 | 30.01 |
| 129 | C2 levels | GCST90468497 | 29.88 |
| 130 | Fibrosis and cirrhosis of liver | FING00000543 | 29.84 |
| 131 | Total protein levels | GCST90018756 | 29.78 |
| 132 | aparc-Desikan lh thickness paracentral | GCST90003461 | 29.71 |
| 133 | Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61) | GCST90668739 | 29.61 |
| 134 | Rheumatoid arthritis | GCST90018690 | 29.43 |
| 135 | PRCP levels | GCST90470314 | 29.37 |
| 136 | TNFRSF13C/TNFSF13B ratio | GCST90315934 | 29.35 |
| 137 | Alcohol drinker status - Current | Alcohol | UKBB00000021 | 29.32 |
| 138 | CD27/DLL1 ratio | GCST90313771 | 29.32 |
| 139 | T1 FreeSurfer aseg Right-Putamen | GCST90384163 | 29.06 |
| 140 | CRTAP levels | GCST90468872 | 29.06 |
| 141 | Cardiorespiratory fitness (vo2 max) | GCST90093317 | 28.99 |
| 142 | Kela-code for severe mental illness | FING00000707 | 28.95 |
| 143 | Bell pepper liking | GCST90094703 | 28.83 |
| 144 | LILRB2 levels | GCST90469777 | 28.71 |
| 145 | Handedness (confirmatory factor analysis Factor 36) | GCST90309370 | 28.62 |
| 146 | Lymphoid leukaemia (controls excluding all cancers) | FING00000741 | 28.11 |
| 147 | CD27/TGFBR2 ratio | GCST90313776 | 28.03 |
| 148 | Bifidobacterium catenulatum abundance in stool | GCST90032224 | 28.00 |
| 149 | FCRL5/ICAM3 ratio | GCST90314802 | 27.94 |
| 150 | Wears glasses or contact lenses | Eyesight | UKBB00000907 | 27.74 |
| 151 | ZNF830 levels | GCST90471102 | 27.74 |
| 152 | TNFRSF13B/TNFRSF13C ratio | GCST90315931 | 27.70 |
| 153 | PGR levels | GCST90470223 | 27.55 |
| 154 | Diseases of middle ear and mastoid | FING00000427 | 27.43 |
| 155 | SLAMF1 levels | GCST90470649 | 27.33 |
| 156 | Lifetime number of sexual partners | Sexual factors | UKBB00000406 | 27.08 |
| 157 | EDA2R levels | GCST90469067 | 27.08 |
| 158 | Types of physical activity in last 4 weeks - Walking for pleasure (not as a means of transport) | Physical activity | UKBB00000875 | 27.02 |
| 159 | CD74 levels | GCST90468647 | 26.78 |
| 160 | Bread type: White (UKB data field 1448_1) | GCST90132964 | 26.75 |
| 161 | Syncope and collapse | symptoms | UKBB00000801 | 26.63 |
| 162 | Bread type - Wholemeal or wholegrain | Diet | UKBB00000107 | 26.38 |
| 163 | Bread type: White vs wholemeal/wholegrain and brown (UKB data field 1448) | GCST90132967 | 26.35 |
| 164 | Principal component-derived dietary pattern 28 | GCST90133033 | 26.04 |
| 165 | CD79B levels | GCST90468648 | 25.82 |
| 166 | Number of days/week walked 10+ minutes | Physical activity | UKBB00000535 | 25.82 |
| 167 | FCRL2/SEMA7A ratio | GCST90314800 | 25.78 |
| 168 | mean corpuscular hemoglobin (MCH, mean, inv-norm transformed) | GCST90475444 | 25.77 |
| 169 | Percentage of monosialylation of core-fucosylated monogalactosylated structures without bisecting GlcNAc (GP41) | GCST90668485 | 25.75 |
| 170 | mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed) | GCST90475448 | 25.74 |
| 171 | Lymphocyte count | GCST90025984 | 25.68 |
| 172 | EPHB6/VWC2 ratio | GCST90314683 | 25.61 |
| 173 | Mother's age | Family history | UKBB00000484 | 25.48 |
| 174 | Diseases of white blood cells (PheCode 288) | GCST90475812 | 25.36 |
| 175 | Types of physical activity in last 4 weeks - Heavy DIY (eg: weeding, lawn mowing, carpentry, digging) | Physical activity | UKBB00000870 | 25.28 |
| 176 | Experiencing mood swings | GCST006944 | 24.89 |
| 177 | S100A11/S100A12 ratio | GCST90315798 | 24.85 |
| 178 | ICAM3/TNFRSF13B ratio | GCST90315124 | 24.84 |
| 179 | F-cooking flavour liking (derived food-liking factor) | GCST90094742 | 24.80 |
| 180 | Left ventricular end systole inferior wall thickness | GCST90278509 | 24.75 |
| 181 | Blood cell traits latent factor 23 (white cell) | GCST90559265 | 24.72 |
| 182 | Skin and soft tissue infections | GCST90013411 | 24.70 |
| 183 | Crisps liking | GCST90094747 | 24.67 |
| 184 | Qualifications - A levels/AS levels or equivalent | Education | UKBB00000727 | 24.63 |
| 185 | QPCT/RNASET2 ratio | GCST90315758 | 24.44 |
| 186 | Fracture of radius and ulna (PheCode 803.2) | GCST90476280 | 24.32 |
| 187 | ADGRE2 levels | GCST90468237 | 24.28 |
| 188 | CD84/TREML2 ratio | GCST90313919 | 24.25 |
| 189 | CD27/CD79B ratio | GCST90313770 | 24.10 |
| 190 | DEFA1_DEFA1B/LCN2 ratio | GCST90314454 | 23.86 |
| 191 | GFRA2 levels | GCST90469329 | 23.85 |
| 192 | Total protein levels | UKBB00000826 | 23.74 |
| 193 | Mineral and other dietary supplements - None of the above | Medication | UKBB00000474 | 23.71 |
| 194 | CD27/FCRL5 ratio | GCST90313772 | 23.65 |
| 195 | Primary biliary cholangitis | GCST003129 | 23.64 |
| 196 | aparc-DKTatlas lh thickness paracentral | GCST90003555 | 23.44 |
| 197 | Lamb or mutton consumption (UKB data field 1379) | GCST90132998 | 23.44 |
| 198 | Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive) | GCST90132227 | 23.16 |
| 199 | Total protein levels | GCST90468105 | 23.08 |
| 200 | LY96 levels | GCST90469823 | 22.97 |
| 201 | CD79B/FCRL1 ratio | GCST90313899 | 22.91 |
| 202 | MAP3K5/MAVS ratio | GCST90315379 | 22.69 |
| 203 | PDGFRB levels | GCST90470192 | 22.69 |
| 204 | CEACAM8/MMP9 ratio | GCST90314002 | 22.64 |
| 205 | CD83/IL12A_IL12B ratio | GCST90313905 | 22.58 |
| 206 | C1QTNF1/COL18A1 ratio | GCST90313551 | 22.47 |
| 207 | wg rh intensity-contrast pericalcarine | GCST90003847 | 22.43 |
| 208 | FCRL5 levels | GCST90469208 | 22.33 |
| 209 | Unspecified dementia | FING00001400 | 22.30 |
| 210 | Disorders of orbit | FING00000449 | 22.28 |
| 211 | HippSubfield rh volume subiculum-body | GCST90002691 | 22.26 |
| 212 | Fed-up feelings | Mental health | UKBB00000242 | 22.21 |
| 213 | Types of physical activity in last 4 weeks - None of the above | Physical activity | UKBB00000872 | 22.19 |
| 214 | CA1/CA3 ratio | GCST90313572 | 22.16 |
| 215 | Red meat liking | GCST90094819 | 22.14 |
| 216 | Leisure/social activities - Other group activity | Social support | UKBB00000400 | 22.02 |
| 217 | lymphocyte (absolute count, mean, inv-norm transformed) | GCST90475426 | 22.00 |
| 218 | CRTAM/LY9 ratio | GCST90314278 | 21.97 |
| 219 | F-sauces liking (derived food-liking factor) | GCST90094831 | 21.89 |
| 220 | Liver liking | GCST90094794 | 21.88 |
| 221 | Use of hypnotics and sedatives | FING00001411 | 21.85 |
| 222 | EFNA4/VWC2 ratio | GCST90314607 | 21.71 |
| 223 | GZMA/IL12A_IL12B ratio | GCST90315009 | 21.67 |
| 224 | Participation in an health questionnaire (not invited vs invited) | GCST90012794 | 21.53 |
| 225 | Acceptance of an invitation to participate in a mental health questionnaire | GCST90012792 | 21.51 |
| 226 | Lamb liking | GCST90094790 | 21.45 |
| 227 | CDKN1A/TACC3 ratio | GCST90313975 | 21.27 |
| 228 | Influenza and pneumonia | FING00000679 | 21.10 |
| 229 | LSP1 levels | GCST90469811 | 21.05 |
| 230 | CLPP/DECR1 ratio | GCST90314137 | 21.05 |
| 231 | Diacylglycerol_33:1_[M+H-H2O]1+ levels | GCST90060173 | 20.83 |
| 232 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60) | GCST90320623 | 20.69 |
| 233 | FAS levels | GCST90469192 | 20.42 |
| 234 | rfMRI connectivity (ICA25 edge 103) | GCST90004746 | 20.40 |
| 235 | Salty food liking | GCST90094828 | 20.36 |
| 236 | Biological Sibling: Cancer, Skin | GCST90476369 | 20.27 |
| 237 | TNFRSF6B levels | GCST90470914 | 20.16 |
| 238 | Mood swings | Mental health | UKBB00000482 | 20.03 |
| 239 | CLEC4G levels | GCST90468774 | 20.02 |
| 240 | C9 Carnitine levels in chronic kidney disease | GCST90257682 | 20.00 |
| 241 | Lymphoid leukemia, chronic (PheCode 204.12) | GCST90475613 | 20.00 |
| 242 | Coffee type: Decaffeinated coffee (any type) (UKB data field 1508_1) | GCST90132974 | 19.93 |
| 243 | Appendectomy | FING00000104 | 19.90 |
| 244 | Use of dietary supplements (confirmatory factor analysis Factor 13) | GCST90309347 | 19.89 |
| 245 | CHI3L1/PRSS8 ratio | GCST90314044 | 19.89 |
| 246 | Irritable bowel syndrome | GCST90016564 | 19.83 |
| 247 | Secondary hypothyroidism (PheCode 244.1) | GCST90475649 | 19.79 |
| 248 | SPINT1/SUSD2 ratio | GCST90315878 | 19.69 |
| 249 | IPCEF1/TBCC ratio | GCST90315188 | 19.61 |
| 250 | Qualifications - Other professional qualifications eg: nursing, teaching | Education | UKBB00000732 | 19.60 |
| 251 | T1 CAT volume L LeftPutamen | GCST90384100 | 19.57 |
| 252 | X-11444 metabolite level | GCST90616545 | 19.55 |
| 253 | Age when finished full-time education (weighted GWA) | GCST90267281 | 19.54 |
| 254 | AFP levels | GCST90468250 | 19.48 |
| 255 | Soy sauce liking | GCST90094844 | 19.42 |
| 256 | Treatment/medication code - ventolin 100micrograms inhaler | Medications | UKBB00000860 | 19.41 |
| 257 | IL12A_IL12B/LAG3 ratio | GCST90315147 | 19.40 |
| 258 | Rheumatoid arthritis | GCST90132224 | 19.38 |
| 259 | TNFRSF4/TNFRSF8 ratio | GCST90315938 | 19.33 |
| 260 | Plasma argininate* levels in chronic kidney disease | GCST90264826 | 19.29 |
| 261 | 3,5-dichloro-2,6-dihydroxybenzoic acid levels | GCST90200252 | 19.27 |
| 262 | Usual side of head for mobile phone use - Left | Electronic device use | UKBB00000889 | 19.10 |
| 263 | Broad bean liking | GCST90094711 | 19.05 |
| 264 | REST UKBBICA NODEamps25 0003 | GCST90385486 | 18.96 |
| 265 | Age completed full time education | Education | UKBB00000013 | 18.87 |
| 266 | Lymphoid neoplasms | GCST90624743 | 18.72 |
| 267 | Left-hemisphere limbic network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302732 | 18.71 |
| 268 | Blood cell traits latent factor 12 (red cell) | GCST90559254 | 18.59 |
| 269 | Osteoarthritis, localized (PheCode 740.1) | GCST90476254 | 18.58 |
| 270 | Illness, injury, bereavement, stress in last 2 years - Financial difficulties | Mental health | UKBB00000338 | 18.44 |
| 271 | CD302/IL12A_IL12B ratio | GCST90313806 | 18.39 |
| 272 | TOP1 levels | GCST90470933 | 18.39 |
| 273 | CNTNAP2 levels | GCST90468808 | 18.35 |
| 274 | Nerve, nerve root and plexus disorders | FING00000862 | 18.34 |
| 275 | Champagne or white wine consumption (glasses per month) (UKB data field 1578, 4418) | GCST90132986 | 18.29 |
| 276 | Suicide or other Intentional self-harm | FING00001345 | 18.25 |
| 277 | IDP T1 FAST ROIs L cerebellum V | GCST90002564 | 18.03 |
| 278 | PECAM1/SOD2 ratio | GCST90315647 | 17.91 |
| 279 | CHIT1 levels | GCST90468744 | 17.90 |
| 280 | T1 FreeSurfer aseg Right-Caudate | GCST90384162 | 17.89 |
| 281 | Usual side of head for mobile phone use - Right | Electronic device use | UKBB00000890 | 17.85 |
| 282 | BLMH/PEAR1 ratio | GCST90313519 | 17.84 |
| 283 | Types of physical activity in last 4 weeks - Strenuous sports | Physical activity | UKBB00000874 | 17.83 |
| 284 | lymphocyte (absolute count, minimum, inv-norm transformed) | GCST90475429 | 17.81 |
| 285 | TNFRSF11A levels | GCST90277644 | 17.75 |
| 286 | Qualifications - O levels/GCSEs or equivalent | Education | UKBB00000731 | 17.70 |
| 287 | IL22 levels | GCST90469582 | 17.66 |
| 288 | DTI TBSS FA Sagittal stratum L | GCST90384411 | 17.63 |
| 289 | Eosinophill percentage | Blood count | UKBB00000207 | 17.56 |
| 290 | DCTN6/TDRKH ratio | GCST90314436 | 17.53 |
| 291 | aparc-DKTatlas rh thickness lingual | GCST90003582 | 17.53 |
| 292 | Eosinophill count | Blood count | UKBB00000206 | 17.42 |
| 293 | Qualifications - None of the above | Education | UKBB00000729 | 17.29 |
| 294 | Physical activity (Relative amplitude) | GCST90061432 | 17.26 |
| 295 | Spleen volume | GCST90016667 | 17.20 |
| 296 | Gut bacterial pathway abundance (PYRIDNUCSYN.PWY..NAD.biosynthesis.I..from.aspartate.) | GCST90027638 | 17.17 |
| 297 | Job involves mainly walking or standing | Employment | UKBB00000384 | 17.16 |
| 298 | Any mental disorder | FING00000100 | 17.16 |
| 299 | Seminoma of testis, excluding all cancers (controls excluding all cancers) | FING00001289 | 17.04 |
| 300 | PIKFYVE levels | GCST90470235 | 17.00 |
| 301 | Multiple sclerosis | GCST90475833 | 16.89 |
| 302 | IL2RB levels | GCST90469586 | 16.87 |
| 303 | BSG/IL12A_IL12B ratio | GCST90313532 | 16.85 |
| 304 | Seropositive rheumatoid arthritis, wide | FING00001298 | 16.80 |
| 305 | lymphocyte (absolute count, maximum, inv-norm transformed) | GCST90475423 | 16.76 |
| 306 | 2,3-dihydroxy-5-methylthio-4-pentenoate (dmtpa) levels | GCST90200233 | 16.72 |
| 307 | CXCL11 levels | GCST90274781 | 16.60 |
| 308 | Right ventricular ejection fraction | GCST90134591 | 16.59 |
| 309 | DTI TBSS L1 Cingulum cingulate gyrus L | GCST90384463 | 16.59 |
| 310 | Left ventricular end systole inferoseptal wall thickness | GCST90278508 | 16.57 |
| 311 | ANPEP/CXADR ratio | GCST90313272 | 16.56 |
| 312 | Prescriptions - antispasmodic | UKBB00000666 | 16.51 |
| 313 | aparc-a2009s rh thickness G-temporal-middle | GCST90003714 | 16.47 |
| 314 | F-strong flavour liking (derived food-liking factor) | GCST90094851 | 16.45 |
| 315 | CD163/MARCO ratio | GCST90313737 | 16.31 |
| 316 | CTSO levels | GCST90468915 | 16.30 |
| 317 | LGALS4 levels | GCST90469762 | 16.17 |
| 318 | ATOX1/TMSB10 ratio | GCST90313377 | 16.13 |
| 319 | WASL levels | GCST90471070 | 16.07 |
| 320 | Aniseed liking | GCST90094689 | 16.04 |
| 321 | ZP3 levels | GCST90471105 | 16.03 |
| 322 | wg lh intensity-contrast cuneus | GCST90003796 | 16.03 |
| 323 | Asthma and allergy | FING00000115 | 16.00 |
| 324 | SKAP1 levels | GCST90470645 | 15.99 |
| 325 | Physical activity (Total log acceleration 10pm-12am) | GCST90061420 | 15.92 |
| 326 | SEPTIN8 levels | GCST90470578 | 15.89 |
| 327 | NOTCH1/SEMA7A ratio | GCST90315545 | 15.87 |
| 328 | T1 CAT volume R RightThalamus | GCST90384097 | 15.87 |
| 329 | Cardiorespiratory fitness slope | GCST90093320 | 15.85 |
| 330 | Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80) | GCST90668758 | 15.84 |
| 331 | Polyglandular dysfunction | FING00001186 | 15.84 |
| 332 | Subjective well-being | GCST90104897 | 15.82 |
| 333 | CABP2 levels | GCST90468519 | 15.79 |
| 334 | F-fruit liking (derived food-liking factor) | GCST90094767 | 15.77 |
| 335 | T1 CAT GM unnormalised volume | GCST90383982 | 15.68 |
| 336 | GFRA2/IL12A_IL12B ratio | GCST90314925 | 15.68 |
| 337 | Benign neoplasm of other and unspecified endocrine glands | FING00000159 | 15.62 |
| 338 | CD38/IL12A_IL12B ratio | GCST90313808 | 15.60 |
| 339 | Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80) | GCST90668524 | 15.53 |
| 340 | Coffee type: Ground coffee (include espresso, filter etc) (UKB data field 1508_3) | GCST90041803 | 15.52 |
| 341 | IDP dMRI ProbtrackX L1 cgc l | GCST90004250 | 15.46 |
| 342 | Clonal haematopoiesis of indeterminate potential (TET2 mutation) | GCST90165281 | 15.46 |
| 343 | Urine N1,N12-diacetylspermine levels in chronic kidney disease | GCST90265683 | 15.39 |
| 344 | Treatment/medication code - levothyroxine sodium | Medications | UKBB00000849 | 15.36 |
| 345 | Shoulder lesions | FING00001303 | 15.32 |
| 346 | IGLC2 levels | GCST90469536 | 15.31 |
| 347 | Chronic obstructive pulmonary disease in current smokers | GCST90016593 | 15.28 |
| 348 | Wears glasses or contact lenses (UKB data field 2207) | GCST90042875 | 15.25 |
| 349 | F9/FURIN ratio | GCST90314747 | 15.25 |
| 350 | Salami liking | GCST90094825 | 15.23 |
| 351 | Principal component-derived dietary pattern 9 | GCST90133014 | 15.22 |
| 352 | ITGB1BP2/PTPN6 ratio | GCST90315218 | 15.20 |
| 353 | Pregnancy with abortive outcome | FING00001205 | 15.19 |
| 354 | Hypercalcemia (PheCode 275.6) | GCST90475748 | 15.14 |
| 355 | HippSubfield rh volume subiculum-head | GCST90002693 | 15.11 |
| 356 | NFATC3 levels | GCST90470034 | 15.09 |
| 357 | IL7R levels | GCST90469605 | 15.08 |
| 358 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T276 | ECGU000276 | 15.05 |
| 359 | PLXNB2/SEMA7A ratio | GCST90315692 | 15.04 |
| 360 | Eosinophil count | GCST90002381 | 14.98 |
| 361 | TCN2 levels | GCST90470820 | 14.97 |
| 362 | CD22/CD79B ratio | GCST90313755 | 14.93 |
| 363 | Eosinophil count | GCST90025987 | 14.92 |
| 364 | Rheumatoid arthritis | GCST000679 | 14.89 |
| 365 | Lysoalkenylphosphatidylethanolamine (P-20:0) levels | GCST90025460 | 14.86 |
| 366 | PCSK7 levels | GCST90470176 | 14.85 |
| 367 | PRTG levels | GCST90470347 | 14.85 |
| 368 | Number of incorrect matches in round | Pairs matching | UKBB00000538 | 14.83 |
| 369 | EZR levels | GCST90469162 | 14.81 |
| 370 | Hypothyroidism, drug reimbursement | FING00000655 | 14.78 |
| 371 | IDP T1 FAST ROIs L cerebellum VIIb | GCST90002575 | 14.77 |
| 372 | Mean sphered cell volume (UKB data field 30270) | GCST90468089 | 14.77 |
| 373 | LYN/TACC3 ratio | GCST90315350 | 14.76 |
| 374 | Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemia | GCST90624744 | 14.67 |
| 375 | Triacylglycerol_51:2_[M+NH4]1+ levels | GCST90060497 | 14.66 |
| 376 | Educational attainment | GCST003496 | 14.55 |
| 377 | Age when finished full-time education (standard GWA) | GCST90267280 | 14.55 |
| 378 | 1,5-anhydroglucitol (1,5-ag) levels | GCST90243529 | 14.54 |
| 379 | GABBR2 levels | GCST90241230 | 14.52 |
| 380 | CD163 levels | GCST90468600 | 14.51 |
| 381 | SSC-A on plasmacytoid Dendritic Cell | GCST90002072 | 14.46 |
| 382 | Eosinophil percentage of white cells | GCST90002382 | 14.45 |
| 383 | POMC levels | GCST90470284 | 14.39 |
| 384 | CD20 on IgD- CD27- B cell | GCST90001754 | 14.39 |
| 385 | CD209/CLEC14A ratio | GCST90313749 | 14.38 |
| 386 | PLXNB2 levels | GCST90470266 | 14.36 |
| 387 | NUBP1 levels | GCST90470100 | 14.34 |
| 388 | Substance use, excluding alcohol | FING00001342 | 14.31 |
| 389 | EIF3J levels | GCST90241122 | 14.31 |
| 390 | LGALS4/PCDH17 ratio | GCST90315315 | 14.23 |
| 391 | SLAMF7 levels | GCST90470651 | 14.23 |
| 392 | Other and/or unspecified nontoxic goitre | FING00000958 | 14.22 |
| 393 | Mean sphered cell volume | Blood count | UKBB00000452 | 14.22 |
| 394 | Beef/steak liking | GCST90094700 | 14.22 |
| 395 | Hereditary hemolytic anemias (PheCode 282) | GCST90475779 | 14.21 |
| 396 | HNRNPK/USP8 ratio | GCST90315070 | 14.20 |
| 397 | ELOA/POLR2F ratio | GCST90314643 | 14.19 |
| 398 | Soft tissue disorders | FING00001316 | 14.08 |
| 399 | aparc-Desikan rh thickness lingual | GCST90003491 | 14.07 |
| 400 | Use of disulfiram, acamprosate or naltrexone | FING00001410 | 14.01 |
| 401 | Cereal type - Oat cereal (e.g. Ready Brek, porridge) | Diet | UKBB00000124 | 14.01 |
| 402 | CD20 on IgD- CD24- B cell | GCST90001753 | 13.99 |
| 403 | PADI2 levels | GCST90470142 | 13.95 |
| 404 | LGALS8/SOD2 ratio | GCST90315320 | 13.92 |
| 405 | Physical activity | GCST90093323 | 13.88 |
| 406 | T1 CAT volume R TemporalFusiformCortexposteriordivision | GCST90384075 | 13.86 |
| 407 | CD160/NCR1 ratio | GCST90313732 | 13.76 |
| 408 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502396 | 13.73 |
| 409 | Body-mass index, inverse-rank normalized | FING00000222 | 13.72 |
| 410 | Myasthenia gravis | GCST90432156 | 13.68 |
| 411 | Mean reticulocyte volume | GCST90025975 | 13.67 |
| 412 | IDP T1 FAST ROIs L postcent gyrus | GCST90002483 | 13.65 |
| 413 | Rheumatoid arthritis | FING00001267 | 13.61 |
| 414 | High myopia | GCST009962 | 13.59 |
| 415 | Cervical cancer | GCST90018597 | 13.53 |
| 416 | Active to sedentary transition probability | GCST90061429 | 13.49 |
| 417 | Depression or dysthymia | FING00000400 | 13.48 |
| 418 | X-11787 levels | GCST90200465 | 13.46 |
| 419 | S100P levels | GCST90470520 | 13.46 |
| 420 | Pure hyperglyceridaemia | FING00001231 | 13.44 |
| 421 | SIT1 levels | GCST90470644 | 13.39 |
| 422 | BA-exvivo rh area perirhinal | GCST90003233 | 13.36 |
| 423 | Eosinophill percentage (UKB data field 30210) | GCST90468069 | 13.35 |
| 424 | Strawberries liking | GCST90094849 | 13.32 |
| 425 | DAB2/FKBP1B ratio | GCST90314362 | 13.29 |
| 426 | Eosinophil count | GCST90002298 | 13.26 |
| 427 | Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers) | FING00000756 | 13.26 |
| 428 | CDHR1 levels | GCST90468678 | 13.25 |
| 429 | CD200/CLEC4G ratio | GCST90313746 | 13.23 |
| 430 | IDP T1 FAST ROIs V cerebellum X | GCST90002588 | 13.20 |
| 431 | wg lh intensity-contrast lingual | GCST90003804 | 13.19 |
| 432 | Right ventricular ejection fraction (MTAG) | GCST90134595 | 13.14 |
| 433 | X-03056--N-[3- 2-Oxopyrrolidin-1-yl propyl]acetamide levels | GCST90243619 | 13.13 |
| 434 | MCAM/NCAM1 ratio | GCST90315408 | 13.10 |
| 435 | TSC1 levels | GCST90470972 | 13.08 |
| 436 | Diseases of the digestive system | FING00000429 | 13.08 |
| 437 | CD28 levels | GCST90468616 | 13.08 |
| 438 | Cardiorespiratory fitness (vo2 max) | GCST90093316 | 13.06 |
| 439 | Seropositive rheumatoid arthritis, strict definition | FING00001297 | 13.04 |
| 440 | Vitamin and mineral supplements - None of the above | Medication | UKBB00000901 | 13.04 |
| 441 | Treatment or medication use - levothyroxine sodium (UKB data field 20003_1141191044) | GCST90042535 | 13.04 |
| 442 | MAMDC4 levels | GCST90469842 | 13.03 |
| 443 | Bread type: Wholemeal or wholegrain (UKB data field 1448_3) | GCST90132966 | 13.02 |
| 444 | PDCD1/TNFRSF9 ratio | GCST90315611 | 13.02 |
| 445 | MGAT2 levels | GCST90089560 | 12.98 |
| 446 | GZMA/LTA ratio | GCST90315012 | 12.96 |
| 447 | Lymphocyte count | GCST90018742 | 12.96 |
| 448 | PLAUR levels | GCST90012051 | 12.93 |
| 449 | SEMA4C levels | GCST90470572 | 12.89 |
| 450 | Non-cancer illness code, self-reported - hypothyroidism/myxoedema | Medical conditions | UKBB00000518 | 12.89 |
| 451 | Left-hemisphere control network to caudate white-matter structural connectivity | GCST90302753 | 12.88 |
| 452 | Triacylglycerol_53:2_[M+NH4]1+ levels | GCST90060531 | 12.87 |
| 453 | Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI) | GCST003658 | 12.86 |
| 454 | Illness, injury, bereavement, stress in last 2 years - None of the above | Mental health | UKBB00000339 | 12.85 |
| 455 | IDP dMRI ProbtrackX OD str l | GCST90004473 | 12.85 |
| 456 | Operation code - wisdom teeth surgery | Operations | UKBB00000569 | 12.84 |
| 457 | TYRP1 levels | GCST90470998 | 12.83 |
| 458 | Moderate-to-vigorous intensity physical activity during leisure time | GCST90104341 | 12.81 |
| 459 | ITGAL levels | GCST90469637 | 12.79 |
| 460 | CD244 levels | GCST90274771 | 12.79 |
| 461 | Burger liking | GCST90094715 | 12.78 |
| 462 | PDCD6IP levels | GCST90618969 | 12.77 |
| 463 | LAIR1 levels | GCST90469728 | 12.75 |
| 464 | ADGRE5/VCAM1 ratio | GCST90313184 | 12.67 |
| 465 | TNFRSF8/TNFRSF9 ratio | GCST90315940 | 12.62 |
| 466 | CD244/TREML2 ratio | GCST90313767 | 12.60 |
| 467 | KIF22 levels | GCST90469682 | 12.58 |
| 468 | DTI TBSS FA Posterior thalamic radiation R | GCST90384408 | 12.58 |
| 469 | AIDA levels | GCST90468265 | 12.56 |
| 470 | 5,6-dihydrouridine levels | GCST90199767 | 12.53 |
| 471 | Avoided activities or situations because of previous stressful experience in past month | Traumatic events | UKBB00000083 | 12.52 |
| 472 | CDKN2D/TACC3 ratio | GCST90313992 | 12.51 |
| 473 | MCTS1 levels | GCST90469874 | 12.49 |
| 474 | Types of physical activity in last 4 weeks - Other exercises (eg: swimming, cycling, keep fit, bowling) | Physical activity | UKBB00000873 | 12.48 |
| 475 | Physical activity | GCST90093322 | 12.48 |
| 476 | Body fat percentage (adjusted for testosterone and SHBG) x sex interaction | GCST90432181 | 12.47 |
| 477 | Mean corpuscular hemoglobin concentration | GCST90018745 | 12.46 |
| 478 | Rheumatoid arthritis | GCST90132223 | 12.41 |
| 479 | Thyroid problems | GCST90475276 | 12.38 |
| 480 | Eosinophil count | GCST004606 | 12.37 |
| 481 | F-cooking vegetables liking (derived food-liking factor) | GCST90094743 | 12.36 |
| 482 | Mean spheric corpuscular volume | GCST90002397 | 12.34 |
| 483 | ADM levels | GCST90468246 | 12.33 |
| 484 | Pain in joint (PheCode 745) | GCST90476262 | 12.33 |
| 485 | Principal component-derived dietary pattern 16 | GCST90133021 | 12.31 |
| 486 | Cucumber liking | GCST90094749 | 12.30 |
| 487 | Time spent watching television (TV) | Physical activity | UKBB00000821 | 12.30 |
| 488 | PPP1R2/USP8 ratio | GCST90315723 | 12.29 |
| 489 | Eosinophil percentage of white cells | GCST004600 | 12.27 |
| 490 | CSF1/IFNGR1 ratio | GCST90314283 | 12.22 |
| 491 | wg lh intensity-contrast caudalmiddlefrontal | GCST90003795 | 12.22 |
| 492 | RTBDN levels | GCST90470505 | 12.17 |
| 493 | Neutrophils and lymphocytes in blood (confirmatory factor analysis Factor 35) | GCST90309369 | 12.17 |
| 494 | Eosinophill count (UKB data field 30150) | GCST90468068 | 12.16 |
| 495 | ICAM3/LY9 ratio | GCST90315121 | 12.14 |
| 496 | CEP85/ZBTB16 ratio | GCST90314026 | 12.12 |
| 497 | T1 CAT volume R RightAccumbens | GCST90384109 | 12.11 |
| 498 | Osteoarthrosis, localized, primary (PheCode 740.11) | GCST90476255 | 12.08 |
| 499 | Repeated disturbing thoughts of stressful experience in past month | Traumatic events | UKBB00000750 | 12.08 |
| 500 | MNDA levels | GCST90469927 | 12.07 |
| 501 | Bread type: Wholemeal/wholegrain vs white and brown (UKB data field 1448) | GCST90132968 | 12.06 |
| 502 | T1 FreeSurfer aseg Right-choroid-plexus | GCST90384170 | 12.06 |
| 503 | S100A14 levels | GCST90470515 | 12.04 |
| 504 | Frailty index | GCST90020053 | 12.03 |
| 505 | Medication use (immunosuppressants) | GCST90018771 | 11.97 |
| 506 | SDK2 levels | GCST90470562 | 11.96 |
| 507 | CD163/ICAM1 ratio | GCST90313735 | 11.92 |
| 508 | T1 CAT volume R RightPutamen | GCST90384101 | 11.86 |
| 509 | CD5/TNFRSF9 ratio | GCST90313862 | 11.81 |
| 510 | Osteoarthrosis (PheCode 740) | GCST90476253 | 11.78 |
| 511 | Treatment/medication code - lansoprazole | Medications | UKBB00000848 | 11.77 |
| 512 | FOLR3/KLK8 ratio | GCST90314868 | 11.74 |
| 513 | Psoriasis vulgaris | GCST90018687 | 11.74 |
| 514 | C36:4 Phosphatidylethanolamine levels in chronic kidney disease | GCST90257357 | 11.72 |
| 515 | Chronic obstructive pulmonary disease in ever smokers | GCST90016588 | 11.70 |
| 516 | CD58/MCAM ratio | GCST90313852 | 11.70 |
| 517 | ERBB4/F3 ratio | GCST90314690 | 11.69 |
| 518 | F-dessert liking (derived food-liking factor) | GCST90094754 | 11.66 |
| 519 | Rotator cuff syndrome | FING00001270 | 11.63 |
| 520 | THBS2 levels | GCST90470854 | 11.62 |
| 521 | ITGB7 levels | GCST90469647 | 11.60 |
| 522 | Neurofibromatosis, type 2 | FING00000867 | 11.55 |
| 523 | Physical activity (Total log acceleration) | GCST90061408 | 11.52 |
| 524 | Osteoarthrosis NOS (PheCode 740.9) | GCST90476256 | 11.50 |
| 525 | Handedness (chirality/laterality) - Right-handed | Early life factors | UKBB00000303 | 11.50 |
| 526 | Other and unspecified tonsillitis | FING00000954 | 11.50 |
| 527 | LTA levels | GCST90469813 | 11.49 |
| 528 | Red cell distribution width variance | GCST90565705 | 11.48 |
| 529 | MAPRE3 levels | GCST90469859 | 11.48 |
| 530 | Prescriptions - anti-malarial | UKBB00000663 | 11.47 |
| 531 | Prescriptions - quinine bisulfate | anti-malarial | UKBB00000698 | 11.47 |
| 532 | Principal component-derived dietary pattern 1 | GCST90133006 | 11.46 |
| 533 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T277 | ECGU000277 | 11.45 |
| 534 | Operative procedures - Closed reduction of fracture of bone and fixation using nail or screw | Summary Operations | UKBB00000575 | 11.43 |
| 535 | Left-hemisphere control network to amygdala white-matter structural connectivity | GCST90302757 | 11.42 |
| 536 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T275 | ECGU000275 | 11.39 |
| 537 | Omega-3 fatty acids to total fatty acids percentage | GCST90502448 | 11.38 |
| 538 | CD48 levels | GCST90425676 | 11.35 |
| 539 | CD93/CLEC14A ratio | GCST90313921 | 11.31 |
| 540 | COL9A1 levels | GCST90468822 | 11.30 |
| 541 | Tyrosine levels | GCST90200427 | 11.30 |
| 542 | ITGB1/ITGB2 ratio | GCST90315225 | 11.29 |
| 543 | Frequency of stair climbing in last 4 weeks | Physical activity | UKBB00000266 | 11.29 |
| 544 | Strenuous sports or other exercises | GCST006100 | 11.29 |
| 545 | Loneliness, isolation | Mental health | UKBB00000408 | 11.27 |
| 546 | Red blood cell count | GCST90278641 | 11.25 |
| 547 | ADM/CLMP ratio | GCST90313197 | 11.23 |
| 548 | Principal component-derived dietary pattern 4 | GCST90133009 | 11.22 |
| 549 | CDKN1A/TXLNA ratio | GCST90313979 | 11.20 |
| 550 | INSR levels | GCST90469623 | 11.16 |
| 551 | GDNF levels | GCST90274792 | 11.12 |
| 552 | LAYN/VWC2 ratio | GCST90315293 | 11.11 |
| 553 | GALNT10/SEMA7A ratio | GCST90314915 | 11.10 |
| 554 | CD27/NECTIN4 ratio | GCST90313775 | 11.09 |
| 555 | KYNU/SCLY ratio | GCST90315265 | 11.06 |
| 556 | Time to complete round | Pairs matching | UKBB00000822 | 11.03 |
| 557 | Gastroesophageal reflux disease | GCST90000514 | 11.03 |
| 558 | N-acetylmethionine levels | GCST90200289 | 11.02 |
| 559 | ARHGAP30 levels | GCST90468354 | 11.02 |
| 560 | Treatment or medication use - insulin product (UKB data field 20003_1140883066) | GCST90042226 | 11.02 |
| 561 | Sleep apnea | GCST90475824 | 11.02 |
| 562 | ADM levels | GCST90011996 | 11.01 |
| 563 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 47) | GCST90320610 | 11.01 |
| 564 | Alcohol usually taken with meals (UKB data field 1618) | GCST90133004 | 11.00 |
| 565 | Hypothyroidism | GCST90468138 | 11.00 |
| 566 | Mineral and other dietary supplements - Fish oil (including cod liver oil) | Medication | UKBB00000472 | 10.97 |
| 567 | aseg lh intensity Cerebellum-Cortex | GCST90003767 | 10.92 |
| 568 | Retinal vascular disorders | FING00001262 | 10.92 |
| 569 | F-vegetarian liking (derived food-liking factor) | GCST90094863 | 10.92 |
| 570 | GBP6 levels | GCST90241368 | 10.88 |
| 571 | Estradiol levels | GCST90012105 | 10.87 |
| 572 | SSC4D levels | GCST90470747 | 10.86 |
| 573 | ITGB2 levels | GCST90469644 | 10.83 |
| 574 | LCN2/PRTN3 ratio | GCST90315307 | 10.80 |
| 575 | EFNA4/TNFRSF9 ratio | GCST90314606 | 10.80 |
| 576 | SORT1/ST6GAL1 ratio | GCST90315869 | 10.80 |
| 577 | Ambidextrousness | GCST90013420 | 10.78 |
| 578 | CRTAM/TNFRSF9 ratio | GCST90314280 | 10.78 |
| 579 | Coffee type - Ground coffee (include espresso, filter etc) | Diet | UKBB00000140 | 10.75 |
| 580 | T1 FreeSurfer aseg Left-Inf-Lat-Vent | GCST90384140 | 10.72 |
| 581 | CAPN3 levels | GCST90468538 | 10.72 |
| 582 | Morning/evening person (chronotype) | Sleep | UKBB00000483 | 10.72 |
| 583 | AV-block | FING00000137 | 10.71 |
| 584 | Comfortable retirement (confirmatory factor analysis Factor 29) | GCST90309363 | 10.71 |
| 585 | STC1 levels | GCST90470761 | 10.68 |
| 586 | SNX2 levels | GCST90470701 | 10.66 |
| 587 | Anxiety disorders (more control exclusions) | FING00000098 | 10.64 |
| 588 | Takes medication for Thyroid problems? | GCST90475277 | 10.64 |
| 589 | CD20 on IgD- CD38- B cell | GCST90001755 | 10.63 |
| 590 | HippSubfield rh volume presubiculum-head | GCST90002695 | 10.58 |
| 591 | Triacylglycerol_51:3_[M+NH4]1+ levels | GCST90060494 | 10.53 |
| 592 | F-capsicum liking (derived food-liking factor) | GCST90094726 | 10.50 |
| 593 | Nephrotic syndrome | GCST90018664 | 10.50 |
| 594 | CHRDL1 levels | GCST90468750 | 10.49 |
| 595 | Ptosis of eyelid | FING00001227 | 10.48 |
| 596 | Hearing aid user | Hearing | UKBB00000309 | 10.47 |
| 597 | aparc-a2009s lh volume G-front-inf-Opercular | GCST90002936 | 10.47 |
| 598 | TIE1 levels | GCST90470863 | 10.46 |
| 599 | Operation code - tonsillectomy +/- adenoids | Operations | UKBB00000567 | 10.43 |
| 600 | CFHR2 levels | GCST90468726 | 10.39 |
| 601 | Duration walking for pleasure | Physical activity | UKBB00000203 | 10.38 |
| 602 | DAPP1/ITGB1BP2 ratio | GCST90314388 | 10.37 |
| 603 | PRAP1 levels | GCST90470312 | 10.37 |
| 604 | Mean carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasound | UKBB00000446 | 10.36 |
| 605 | Seen doctor (GP) for nerves, anxiety, tension or depression | Mental health | UKBB00000765 | 10.35 |
| 606 | BBQ/grilled meat liking | GCST90094698 | 10.34 |
| 607 | ARTN levels | GCST90468372 | 10.33 |
| 608 | Psoriatic arthritis vs Cutaneous psoriasis | GCST90243957 | 10.32 |
| 609 | GZMB levels | GCST90469424 | 10.31 |
| 610 | Plasma 1-methylurate levels in chronic kidney disease | GCST90264240 | 10.29 |
| 611 | Apples liking | GCST90094691 | 10.27 |
| 612 | IBD (strict) with PSC | FING00000657 | 10.25 |
| 613 | CXCL5/PLXNA4 ratio | GCST90314351 | 10.22 |
| 614 | CXCL17/LAMP3 ratio | GCST90314340 | 10.17 |
| 615 | ADAM12 levels | GCST90468216 | 10.15 |
| 616 | CCL3 levels | GCST90468582 | 10.14 |
| 617 | CLEC4G/MERTK ratio | GCST90314121 | 10.13 |
| 618 | TGFA levels | GCST90470842 | 10.13 |
| 619 | Fracture of upper limb (PheCode 803) | GCST90476279 | 10.11 |
| 620 | LTA/LTBR ratio | GCST90315336 | 10.11 |
| 621 | Age high blood pressure diagnosed | Medical conditions | UKBB00000016 | 10.08 |
| 622 | DCTPP1 levels | GCST90468961 | 10.01 |
| 623 | Right-hemisphere control network to right-hemisphere control network white-matter structural connectivity | GCST90302834 | 9.97 |
| 624 | Cervicobrachial syndrome | FING00000266 | 9.96 |
| 625 | Vitamin and mineral supplements - Multivitamins +/- minerals | Medication | UKBB00000900 | 9.95 |
| 626 | REG3A levels | GCST90470449 | 9.92 |
| 627 | Primary biliary cholangitis (PBC) | FING00001211 | 9.91 |
| 628 | Brussel sprout liking | GCST90094714 | 9.91 |
| 629 | Beans liking | GCST90094699 | 9.90 |
| 630 | Chalazion | FING00000267 | 9.85 |
| 631 | Ulcerative colitis | GCST90018713 | 9.85 |
| 632 | aparc-a2009s lh volume S-circular-insula-sup | GCST90002973 | 9.84 |
| 633 | L1CAM levels | GCST90469723 | 9.84 |
| 634 | GSTA4 levels | GCST90241283 | 9.84 |
| 635 | ADGRE1 levels | GCST90468236 | 9.78 |
| 636 | DTI autoptx FA ilf r tract | GCST90385127 | 9.72 |
| 637 | CWC15 levels | GCST90468920 | 9.65 |
| 638 | TDRKH/TST ratio | GCST90315913 | 9.64 |
| 639 | Frailty (Factor 2 - Unhealthy Lifestyle) | GCST90624048 | 9.63 |
| 640 | Sleep duration | GCST003839 | 9.61 |
| 641 | Friendships satisfaction | Mental health | UKBB00000273 | 9.59 |
| 642 | CD6 levels | GCST90468644 | 9.59 |
| 643 | Symptoms concerning nutrition, metabolism, and development (PheCode 1002) | GCST90475556 | 9.59 |
| 644 | aseg rh intensity Cerebellum-Cortex | GCST90003781 | 9.59 |
| 645 | mean corpuscular volume (MCV, maximum, inv-norm transformed) | GCST90475466 | 9.58 |
| 646 | CCR2 on CD14+ CD16- monocyte | GCST90002004 | 9.57 |
| 647 | lymphocyte (fraction, minimum, inv-norm transformed) | GCST90475438 | 9.52 |
| 648 | Eosinophil percentage of granulocytes | GCST004617 | 9.52 |
| 649 | Leisure screen time | GCST90104339 | 9.52 |
| 650 | ADGRE5/SEMA7A ratio | GCST90313183 | 9.52 |
| 651 | Illnesses of siblings - Heart disease | Family history | UKBB00000351 | 9.50 |
| 652 | mean corpuscular volume (MCV, mean, inv-norm transformed) | GCST90475470 | 9.50 |
| 653 | Insomnia (weighted GWA) | GCST90267287 | 9.50 |
| 654 | Triacylglycerol_52:2_[M+NH4]1+ levels | GCST90060511 | 9.49 |
| 655 | Lysophosphatidylcholine_16:1_[M+H]1+/Lysophosphatidylethanolamine_19:1_[M+H]1+ levels | GCST90060148 | 9.49 |
| 656 | BCR/ITGB1BP2 ratio | GCST90313494 | 9.49 |
| 657 | Age at first sexual intercourse | GCST90000045 | 9.47 |
| 658 | Mean reticulocyte volume | Blood count | UKBB00000451 | 9.47 |
| 659 | CPA2/ITGB7 ratio | GCST90314207 | 9.46 |
| 660 | Educational attainment | GCST002598 | 9.44 |
| 661 | F-highly palatable foods liking (derived food-liking factor) | GCST90094785 | 9.42 |
| 662 | All pneumoniae | FING00000065 | 9.42 |
| 663 | CD70 levels | GCST90468645 | 9.41 |
| 664 | F-salty food liking (derived food-liking factor) | GCST90094827 | 9.41 |
| 665 | CLEC4G/NELL2 ratio | GCST90314122 | 9.40 |
| 666 | Disorders of vitreous body | FING00000465 | 9.39 |
| 667 | Multiple myeloma and malignant plasma cell neoplasms (controls excluding all cancers) | FING00000843 | 9.39 |
| 668 | FGF21 levels | GCST90274788 | 9.39 |
| 669 | mean corpuscular volume (MCV, minimum, inv-norm transformed) | GCST90475474 | 9.37 |
| 670 | F-sweetened coffee drink liking (derived food-liking factor) | GCST90094853 | 9.34 |
| 671 | CCL5/TACC3 ratio | GCST90313707 | 9.32 |
| 672 | Spinal stenosis | musculoskeletal | UKBB00000792 | 9.32 |
| 673 | Age first had sexual intercourse | Sexual factors | UKBB00000014 | 9.30 |
| 674 | Current employment status - In paid employment or self-employed | Employment | UKBB00000158 | 9.29 |
| 675 | Handedness (chirality/laterality) - Left-handed | Early life factors | UKBB00000302 | 9.29 |
| 676 | FUT8/TNFSF14 ratio | GCST90314895 | 9.28 |
| 677 | DTI autoptx FA ifo l tract | GCST90385124 | 9.27 |
| 678 | Principal component-derived dietary pattern 29 | GCST90133034 | 9.27 |
| 679 | CEACAM8/PGLYRP1 ratio | GCST90314003 | 9.25 |
| 680 | SUSD2 levels | GCST90470787 | 9.25 |
| 681 | Roast chicken liking | GCST90094821 | 9.25 |
| 682 | DIPK2B levels | GCST90468996 | 9.24 |
| 683 | NTN1 levels | GCST90242047 | 9.23 |
| 684 | PPP1R2/TACC3 ratio | GCST90315719 | 9.22 |
| 685 | Generalized anxiety disorder | FING00000566 | 9.21 |
| 686 | Schizophrenia or delusion (more control exclusions) | FING00001278 | 9.20 |
| 687 | Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers) | FING00000846 | 9.19 |
| 688 | DTI autoptx FA ifo r tract | GCST90385125 | 9.18 |
| 689 | Other hypothyroidism | Disorders of thyroid gland | UKBB00000611 | 9.17 |
| 690 | Working memory | GCST90503116 | 9.16 |
| 691 | SERPINA9 levels | GCST90470588 | 9.15 |
| 692 | Triacylglycerol_52:1_[M+NH4]1+ levels | GCST90060515 | 9.14 |
| 693 | B2M levels | GCST90468409 | 9.13 |
| 694 | Sum eosinophil basophil counts | GCST004624 | 9.12 |
| 695 | BMP7 levels | GCST90088157 | 9.11 |
| 696 | Triglycerides | GCST90018755 | 9.07 |
| 697 | FOXO1/USP8 ratio | GCST90314879 | 9.03 |
| 698 | IL1RL1 levels | GCST90469574 | 8.98 |
| 699 | IDP dMRI ProbtrackX L3 ptr r | GCST90004320 | 8.96 |
| 700 | Risk taking | Mental health | UKBB00000759 | 8.94 |
| 701 | CD48/SLAMF7 ratio | GCST90313842 | 8.92 |
| 702 | NUDT5/TXNRD1 ratio | GCST90315582 | 8.92 |
| 703 | neutrophil (fraction, mean, inv-norm transformed) | GCST90475538 | 8.91 |
| 704 | CD58/MEGF10 ratio | GCST90313853 | 8.89 |
| 705 | IDP dMRI TBSS FA Posterior thalamic radiation L | GCST90003906 | 8.88 |
| 706 | PITHD1 levels | GCST90470239 | 8.88 |
| 707 | Volume of right cortical nucleus | GCST90475033 | 8.85 |
| 708 | CA3/HMBS ratio | GCST90313584 | 8.85 |
| 709 | Triacylglycerol_50:4_[M+NH4]1+ levels | GCST90060466 | 8.84 |
| 710 | CD109 levels | GCST90468597 | 8.83 |
| 711 | Light-intensity physical activity duration | GCST90061421 | 8.83 |
| 712 | Maximum digits remembered correctly | Numeric memory | UKBB00000430 | 8.82 |
| 713 | Skin color (cheek, ITA value) | GCST90502780 | 8.82 |
| 714 | wg rh intensity-contrast lateraloccipital | GCST90003837 | 8.81 |
| 715 | Prescriptions - thyroid hormone | hormone | UKBB00000705 | 8.81 |
| 716 | Prescriptions - levothyroxine | thyroid hormone | UKBB00000687 | 8.81 |
| 717 | Current employment status - Retired | Employment | UKBB00000159 | 8.80 |
| 718 | IDP T1 FAST ROIs R cerebellum V | GCST90002565 | 8.79 |
| 719 | Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523 | FING00000304 | 8.79 |
| 720 | Cholelithiasis | GCST90468118 | 8.79 |
| 721 | Osteochondrodysplasia with defects of growth of tubular bones and spine | FING00000910 | 8.79 |
| 722 | NFASC levels | GCST90470031 | 8.79 |
| 723 | COLEC12/TAFA5 ratio | GCST90314185 | 8.76 |
| 724 | Emotionally unstable personality disorder | FING00000495 | 8.75 |
| 725 | Left-hemisphere salience/ventral attention network to amygdala white-matter structural connectivity | GCST90302724 | 8.74 |
| 726 | IDP dMRI ProbtrackX FA fma | GCST90003935 | 8.74 |
| 727 | ICD10 O13: Gestational hypertension | GCST90454232 | 8.73 |
| 728 | Family relationship satisfaction | Mental health | UKBB00000238 | 8.73 |
| 729 | SUOX levels | GCST90470785 | 8.73 |
| 730 | Lymphocyte percentage of white cells | GCST90002389 | 8.72 |
| 731 | Other diseases of upper respiratory tract | FING00001012 | 8.69 |
| 732 | KEL levels | GCST90469673 | 8.68 |
| 733 | Hypothyroidism NOS | endocrine/metabolic | UKBB00000336 | 8.67 |
| 734 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121) | GCST90320684 | 8.67 |
| 735 | Percentage of fucosylation of monogalactosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP82) | GCST90668526 | 8.67 |
| 736 | Thyroid cancer (PheCode 193) | GCST90475600 | 8.67 |
| 737 | Chicken liking | GCST90094732 | 8.66 |
| 738 | SEMA7A levels | GCST90470575 | 8.64 |
| 739 | Lymphocyte percentage (UKB data field 30180) | GCST90468083 | 8.63 |
| 740 | TIMD4 levels | GCST90470866 | 8.63 |
| 741 | Alzheimer's disease | GCST90027158 | 8.62 |
| 742 | Viral warts & HPV (PheCode 78) | GCST90475555 | 8.59 |
| 743 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T283 | ECGU000283 | 8.59 |
| 744 | Frailty (Factor 4 - Metabolic Problems) | GCST90624050 | 8.58 |
| 745 | Thyroid peroxidase antibody levels in pregnancy | GCST90435201 | 8.58 |
| 746 | Hypothyroidism | GCST90319320 | 8.57 |
| 747 | CD4/LILRB4 ratio | GCST90313843 | 8.57 |
| 748 | CTSC levels | GCST90468909 | 8.57 |
| 749 | FOLR2/MSR1 ratio | GCST90314866 | 8.54 |
| 750 | DRAXIN levels | GCST90469038 | 8.54 |
| 751 | BSG/LY9 ratio | GCST90313534 | 8.53 |
| 752 | DTI TBSS L2 Sagittal stratum L | GCST90384507 | 8.52 |
| 753 | Early-onset myasthenia gravis | GCST90093465 | 8.52 |
| 754 | Ceramide (d18:2/22:0) levels | GCST90024682 | 8.48 |
| 755 | T1 FreeSurfer aseg Left-Caudate | GCST90384144 | 8.48 |
| 756 | Physical activity (Total log acceleration 6pm-8pm) | GCST90061418 | 8.45 |
| 757 | Shortness of breath (PheCode 512.7) | GCST90476040 | 8.41 |
| 758 | Dried fruit intake | Diet | UKBB00000193 | 8.41 |
| 759 | Neutrophil percentage of white cells | GCST90002399 | 8.40 |
| 760 | Feeling fed-up | GCST006947 | 8.40 |
| 761 | Lymphocyte percentage | Blood count | UKBB00000412 | 8.40 |
| 762 | Mean corpuscular volume | GCST90018746 | 8.38 |
| 763 | PFKFB2/SRP14 ratio | GCST90315650 | 8.38 |
| 764 | Microscopic polyangiitis | FING00000817 | 8.34 |
| 765 | QPCT levels | GCST90470401 | 8.32 |
| 766 | Neutrophill percentage (UKB data field 30200) | GCST90468093 | 8.28 |
| 767 | CD74/NPDC1 ratio | GCST90313895 | 8.27 |
| 768 | Hypothyroidism | endocrine/metabolic | UKBB00000335 | 8.27 |
| 769 | ASAH2 levels | GCST90468374 | 8.25 |
| 770 | Age at first sexual intercourse | GCST90000047 | 8.25 |
| 771 | VCAM1 levels | GCST90471031 | 8.25 |
| 772 | Staphylococcus A fleurettii abundance in stool | GCST90032564 | 8.24 |
| 773 | Mean reticulocyte volume (UKB data field 30260) | GCST90468088 | 8.24 |
| 774 | Mean reticulocyte volume | GCST90002396 | 8.23 |
| 775 | METAP2/PFKFB2 ratio | GCST90315431 | 8.23 |
| 776 | Average total household income before tax | Household | UKBB00000081 | 8.21 |
| 777 | ATP5IF1/FXN ratio | GCST90313386 | 8.21 |
| 778 | FCRL3 levels | GCST90469207 | 8.19 |
| 779 | ADH4/SCLY ratio | GCST90313195 | 8.15 |
| 780 | AZU1/CEACAM8 ratio | GCST90313424 | 8.13 |
| 781 | Chronic iridocyclitis | FING00000287 | 8.11 |
| 782 | Irritable bowel syndrome | FING00000702 | 8.07 |
| 783 | Neutrophill percentage | Blood count | UKBB00000498 | 8.07 |
| 784 | SLC4A1 levels | GCST90470663 | 8.07 |
| 785 | Mean corpuscular volume | GCST90002335 | 8.06 |
| 786 | F-wine liking (derived food-liking factor) | GCST90094872 | 8.06 |
| 787 | Principal component-derived dietary pattern 36 | GCST90133041 | 8.05 |
| 788 | MMP8/OLR1 ratio | GCST90315464 | 8.05 |
| 789 | Triacylglycerol_50:3_[M+NH4]1+ levels | GCST90060468 | 8.04 |
| 790 | Red cell distribution width | GCST90025988 | 8.04 |
| 791 | Mean corpuscular hemoglobin concentration | GCST90002329 | 8.03 |
| 792 | Neutrophil percentage of granulocytes | GCST004623 | 8.03 |
| 793 | IL12A or IL12B levels | GCST90469548 | 8.03 |
| 794 | CRTAM levels | GCST90468871 | 8.02 |
| 795 | ROR1/TNFRSF21 ratio | GCST90315787 | 8.00 |
| 796 | aparc-a2009s rh thickness G-oc-temp-med-Lingual | GCST90003698 | 8.00 |
| 797 | RNASET2 levels | GCST90470481 | 7.99 |
| 798 | Number of days/week of moderate physical activity 10+ minutes | Physical activity | UKBB00000533 | 7.99 |
| 799 | CCN2/VEGFC ratio | GCST90313719 | 7.97 |
| 800 | FOLH1 levels | GCST90425661 | 7.96 |
| 801 | VAMP5 levels | GCST90471024 | 7.95 |
| 802 | BIN1 levels | GCST90090757 | 7.95 |
| 803 | FAM151A levels | GCST90242450 | 7.94 |
| 804 | Triacylglycerol_48:3_[M+NH4]1+ levels | GCST90060418 | 7.93 |
| 805 | 4-androsten-3beta,17beta-diol disulfate 1 levels | GCST90243879 | 7.93 |
| 806 | HDAC8 levels | GCST90469438 | 7.92 |
| 807 | GOLM2/ITGA5 ratio | GCST90314951 | 7.92 |
| 808 | Diabetes (weighted GWA) | GCST90267279 | 7.91 |
| 809 | CILP levels | GCST90468754 | 7.91 |
| 810 | Allergy/adverse effect of penicillin | injuries & poisonings | UKBB00000028 | 7.89 |
| 811 | Postinflammatory pulmonary fibrosis (PheCode 502) | GCST90476032 | 7.87 |
| 812 | Thyrotoxicosis with diffuse goitre | FING00001361 | 7.87 |
| 813 | HippSubfield rh volume CA4-body | GCST90002705 | 7.87 |
| 814 | Left-hemisphere visual network to left-hemisphere control network white-matter structural connectivity | GCST90302653 | 7.85 |
| 815 | DTI autoptx L1 cst l tract | GCST90385147 | 7.85 |
| 816 | Hypothyroidism | GCST90204167 | 7.84 |
| 817 | Pain type(s) experienced in last month - Stomach or abdominal pain | Pain | UKBB00000633 | 7.83 |
| 818 | IDP dMRI TBSS OD Posterior corona radiata L | GCST90004429 | 7.83 |
| 819 | TNFRSF11A levels | GCST90470902 | 7.83 |
| 820 | Mosaic chromosomal alteration of the X chromosome | GCST90165287 | 7.82 |
| 821 | CLK2 levels | GCST90240975 | 7.81 |
| 822 | CD163/FOLR2 ratio | GCST90313734 | 7.81 |
| 823 | FCER1A levels | GCST90469198 | 7.81 |
| 824 | ALCAM/LRRC25 ratio | GCST90313239 | 7.80 |
| 825 | ENPP5 levels | GCST90469116 | 7.80 |
| 826 | PAM levels | GCST90470156 | 7.80 |
| 827 | GALNT5 levels | GCST90469298 | 7.80 |
| 828 | Time spent driving | Physical activity | UKBB00000818 | 7.79 |
| 829 | LAMP3 levels | GCST90469735 | 7.78 |
| 830 | Triglyceride levels in very large HDL | GCST90132636 | 7.76 |
| 831 | HippSubfield rh volume CA4-head | GCST90002704 | 7.76 |
| 832 | Curry liking | GCST90094750 | 7.75 |
| 833 | Principal component-derived dietary pattern 18 | GCST90133023 | 7.75 |
| 834 | BLVRB/CA1 ratio | GCST90313521 | 7.74 |
| 835 | PGLYRP1 levels | GCST90470219 | 7.74 |
| 836 | Lymphocyte percentage of white cells | GCST004632 | 7.73 |
| 837 | Skin sebum (glabella) | GCST90502797 | 7.72 |
| 838 | RAP1A levels | GCST90470425 | 7.72 |
| 839 | KDM3A levels | GCST90469671 | 7.69 |
| 840 | Biological Father: High blood pressure | GCST90475243 | 7.68 |
| 841 | Sphingomyelin_33:1_[M+H]1+ levels | GCST90060229 | 7.67 |
| 842 | CD164/CD99 ratio | GCST90313740 | 7.67 |
| 843 | BAP18 levels | GCST90468422 | 7.67 |
| 844 | CLEC4A levels | GCST90468771 | 7.66 |
| 845 | MMP8/TGFA ratio | GCST90315466 | 7.65 |
| 846 | APBB1IP/POLR2F ratio | GCST90313300 | 7.65 |
| 847 | aparc-DKTatlas rh volume postcentral | GCST90002913 | 7.64 |
| 848 | CCDC50 levels | GCST90468561 | 7.63 |
| 849 | Corneal edema (PheCode 364.2) | GCST90475862 | 7.61 |
| 850 | BA-exvivo rh area BA6 | GCST90003227 | 7.59 |
| 851 | CD244/CRTAM ratio | GCST90313763 | 7.58 |
| 852 | wg rh intensity-contrast precentral | GCST90003850 | 7.57 |
| 853 | FASLG levels | GCST90469191 | 7.56 |
| 854 | LGALS3BP levels | GCST90469760 | 7.56 |
| 855 | eosinophil (fraction, mean, inv-norm transformed) | GCST90475300 | 7.55 |
| 856 | CKAP4/LAMP3 ratio | GCST90314073 | 7.53 |
| 857 | All influenza | FING00000064 | 7.53 |
| 858 | Acute upper respiratory infections | FING00000034 | 7.53 |
| 859 | CREG1 levels | GCST90468857 | 7.51 |
| 860 | wg rh intensity-contrast paracentral | GCST90003843 | 7.51 |
| 861 | PADI4 levels | GCST90470143 | 7.49 |
| 862 | wg lh intensity-contrast lateraloccipital | GCST90003802 | 7.49 |
| 863 | Thyroid peroxidase antibody positivity in pregnancy | GCST90435202 | 7.48 |
| 864 | Spherical power (right) | Autorefraction | UKBB00000791 | 7.48 |
| 865 | F-salad vegetables liking (derived food-liking factor) | GCST90094824 | 7.47 |
| 866 | Alzheimer's disease (late onset) | GCST002245 | 7.44 |
| 867 | LAIR2 levels | GCST90469729 | 7.43 |
| 868 | red blood cell count (RBC, maximum, inv-norm transformed) | GCST90476343 | 7.43 |
| 869 | Mean platelet thrombocyte volume (UKB data field 30100) | GCST90468087 | 7.43 |
| 870 | Left ventricular end diastolic mass | GCST90268123 | 7.42 |
| 871 | Biological Mother: High blood pressure | GCST90475490 | 7.41 |
| 872 | FAM171B levels | GCST90090339 | 7.40 |
| 873 | Pain type(s) experienced in last month - None of the above | Pain | UKBB00000631 | 7.39 |
| 874 | Age hay fever, rhinitis or eczema diagnosed | Medical conditions | UKBB00000015 | 7.39 |
| 875 | NME3 levels | GCST90470055 | 7.39 |
| 876 | PRTN3/RETN ratio | GCST90315734 | 7.38 |
| 877 | Mineral and other dietary supplements - Calcium | Medication | UKBB00000471 | 7.38 |
| 878 | Diseases of external ear | FING00000424 | 7.37 |
| 879 | CCL3 levels | GCST90012055 | 7.37 |
| 880 | rfMRI amplitudes (ICA100 node 27) | GCST90004615 | 7.36 |
| 881 | 1-palmitoylglycerophosphoethanolamine levels | GCST90243835 | 7.35 |
| 882 | Ever unenthusiastic/disinterested for a whole week | Mental health | UKBB00000226 | 7.35 |
| 883 | Kiwi liking | GCST90094788 | 7.35 |
| 884 | Enthesopathies of lower limb, excluding foot | FING00000509 | 7.34 |
| 885 | PCDH1/TNFRSF11A ratio | GCST90315608 | 7.31 |
| 886 | C1R levels | GCST90468493 | 7.31 |
| 887 | Uterine fibroids | GCST90468154 | 7.30 |
| 888 | Liver fat | GCST90029073 | 7.30 |
| 889 | How are people in household related to participant - Husband, wife or partner | Household | UKBB00000330 | 7.30 |
| 890 | CLEC4C levels | GCST90468772 | 7.30 |
| 891 | Number of sexual partners in opposite-sex sexual behavior | GCST90026481 | 7.27 |
| 892 | RCC1 levels | GCST90470443 | 7.27 |
| 893 | PTPRC levels | GCST90470380 | 7.26 |
| 894 | Principal component-derived dietary pattern 12 | GCST90133017 | 7.25 |
| 895 | Ventricular arrhythmia | GCST90018720 | 7.24 |
| 896 | Fracture of hand or wrist (PheCode 804) | GCST90476281 | 7.24 |
| 897 | Follicular lymphoma, hilmo (controls excluding all cancers) | FING00000548 | 7.23 |
| 898 | Drinks usually with meals in current drinkers (yes and it varies vs no) (UKB data field 1618) | GCST90132925 | 7.23 |
| 899 | SNAP25 levels | GCST90422083 | 7.22 |
| 900 | CRTAM/ICAM3 ratio | GCST90314276 | 7.22 |
| 901 | T1 CAT volume R InsularCortex | GCST90384003 | 7.21 |
| 902 | Blood cell traits latent factor 9 (white cell) | GCST90559251 | 7.21 |
| 903 | Testosterone | Blood biochemistry | UKBB00000816 | 7.21 |
| 904 | TNFRSF9 levels | GCST90470916 | 7.21 |
| 905 | CRKL/MANF ratio | GCST90314269 | 7.20 |
| 906 | rfMRI connectivity (ICA100 edge 495) | GCST90005348 | 7.20 |
| 907 | Nonsuppurative otitis media | FING00000885 | 7.18 |
| 908 | S100A11/SERPINB8 ratio | GCST90315799 | 7.18 |
| 909 | Takes medication for Chronic lung diseases including COPD, Emphysema and Bronchitis? | GCST90475273 | 7.17 |
| 910 | Cheese intake | Diet | UKBB00000127 | 7.15 |
| 911 | NMNAT1 levels | GCST90470057 | 7.15 |
| 912 | IDP T1 FAST ROIs L cerebellum X | GCST90002587 | 7.14 |
| 913 | IDP T1 FAST ROIs R cerebellum crus II | GCST90002574 | 7.14 |
| 914 | LAYN/TNFRSF4 ratio | GCST90315291 | 7.13 |
| 915 | N-acetyltaurine levels | GCST90199967 | 7.13 |
| 916 | IDP dMRI TBSS MO Posterior limb of internal capsule L | GCST90003971 | 7.12 |
| 917 | Red blood cell count | GCST90018751 | 7.12 |
| 918 | BA-exvivo lh thickness MT | GCST90003524 | 7.11 |
| 919 | T1 FreeSurfer aseg Left-choroid-plexus | GCST90384156 | 7.11 |
| 920 | PTPRS levels | GCST90470387 | 7.10 |
| 921 | DTI TBSS L2 Posterior thalamic radiation R | GCST90384504 | 7.09 |
| 922 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 102) | GCST90320665 | 7.09 |
| 923 | PCDH17/SEMA7A ratio | GCST90315605 | 7.09 |
| 924 | CD48/CRTAM ratio | GCST90313839 | 7.08 |
| 925 | F-acquired taste liking (derived food-liking factor) | GCST90094791 | 7.06 |
| 926 | FXYD5/TMSB10 ratio | GCST90314906 | 7.05 |
| 927 | wg lh intensity-contrast rostralmiddlefrontal | GCST90003818 | 7.04 |
| 928 | NOTCH1 levels | GCST90470065 | 7.04 |
| 929 | OMD/SPP1 ratio | GCST90315586 | 7.03 |
| 930 | Never eat eggs, dairy, wheat, sugar - Sugar or foods/drinks containing sugar | Diet | UKBB00000501 | 7.02 |
| 931 | HippSubfield lh volume CA4-body | GCST90002683 | 7.01 |
| 932 | Other dyspnea (PheCode 512.9) | GCST90476042 | 7.01 |
| 933 | ICAM2/IL7R ratio | GCST90315117 | 7.01 |
| 934 | IDP T1 FAST ROIs L subcallosal cortex | GCST90002503 | 7.00 |
| 935 | C1QL2 levels | GCST90468487 | 7.00 |
| 936 | monocyte (fraction, mean, inv-norm transformed) | GCST90475511 | 7.00 |
| 937 | Blood cell traits latent factor 4 (red cell) | GCST90559246 | 7.00 |
| 938 | Mean platelet (thrombocyte) volume | Blood count | UKBB00000450 | 6.99 |
| 939 | PFKM levels | GCST90618802 | 6.99 |
| 940 | Pollock liking | GCST90094813 | 6.99 |
| 941 | Right ventricular end systolic volume | GCST90134589 | 6.98 |
| 942 | Gestational [pregnancy-induced] oedema and proteinuria without hypertension | FING00000572 | 6.97 |
| 943 | Telomere length (principal component 1) | GCST90435144 | 6.96 |
| 944 | CD160/CXCL16 ratio | GCST90313728 | 6.93 |
| 945 | SIGLEC1 levels | GCST90470632 | 6.93 |
| 946 | Salad / raw vegetable intake | Diet | UKBB00000761 | 6.93 |
| 947 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 3) | GCST90320566 | 6.92 |
| 948 | Takes medication for Skin condition (ex. Eczema, Psoriasis)? | GCST90475275 | 6.91 |
| 949 | Benign neoplasm: Adrenal gland | FING00000164 | 6.91 |
| 950 | Urinary albumin-to-creatinine ratio | GCST009640 | 6.90 |
| 951 | Varicose veins of lower extremity, symptomtic (PheCode 454.11) | GCST90476014 | 6.90 |
| 952 | ITGB1BP2/MITD1 ratio | GCST90315214 | 6.89 |
| 953 | Left-hemisphere visual network to right-hemisphere control network white-matter structural connectivity | GCST90302660 | 6.87 |
| 954 | Phospholipid levels in very large HDL | GCST90093012 | 6.87 |
| 955 | GHRL levels | GCST90469341 | 6.87 |
| 956 | MGLL/MITD1 ratio | GCST90315436 | 6.85 |
| 957 | IL12B levels | GCST90469549 | 6.84 |
| 958 | Depressive symptomatology (confirmatory factor analysis Factor 2) | GCST90309337 | 6.84 |
| 959 | PDZK1 levels | GCST90470203 | 6.84 |
| 960 | LCN2/PGLYRP1 ratio | GCST90315306 | 6.84 |
| 961 | Rheumatoid arthritis and other inflammatory polyarthropathies | musculoskeletal | UKBB00000758 | 6.82 |
| 962 | T1 CAT volume L VIIIb | GCST90384130 | 6.82 |
| 963 | Total Phosphatidylcholine levels | GCST90025204 | 6.81 |
| 964 | AXL levels | GCST90468406 | 6.81 |
| 965 | F-fatty food liking (derived food-liking factor) | GCST90094761 | 6.81 |
| 966 | aseg rh volume Amygdala | GCST90002642 | 6.80 |
| 967 | TACC3/TBC1D23 ratio | GCST90315900 | 6.79 |
| 968 | Degenerative skin conditions and other dermatoses (PheCode 702) | GCST90476202 | 6.79 |
| 969 | Red blood cell erythrocyte distribution width (UKB data field 30070) | GCST90468099 | 6.76 |
| 970 | Aplastic anemia (PheCode 284) | GCST90475783 | 6.76 |
| 971 | SNX18 levels | GCST90470700 | 6.75 |
| 972 | FCAMR levels | GCST90469196 | 6.74 |
| 973 | Neutrophil percentage of white cells | GCST004633 | 6.74 |
| 974 | SNX15 levels | GCST90470699 | 6.71 |
| 975 | CRISP2 levels | GCST90468865 | 6.71 |
| 976 | Age at onset of walking | GCST90651078 | 6.71 |
| 977 | Financial situation satisfaction | Mental health | UKBB00000249 | 6.71 |
| 978 | 5-hydroxyindole sulfate levels | GCST90200050 | 6.71 |
| 979 | N-formylanthranilic acid levels | GCST90199960 | 6.70 |
| 980 | Suppurative and unspecified otitis media | FING00001346 | 6.69 |
| 981 | ALPP levels | GCST90468286 | 6.68 |
| 982 | SCARF2/TNFRSF21 ratio | GCST90315813 | 6.65 |
| 983 | CDSN/LY6D ratio | GCST90313997 | 6.64 |
| 984 | ARSA/CD164 ratio | GCST90313351 | 6.64 |
| 985 | monocyte (fraction, maximum, inv-norm transformed) | GCST90475508 | 6.64 |
| 986 | IDP dMRI TBSS MO Cerebral peduncle L | GCST90003967 | 6.63 |
| 987 | Hearing aid use | GCST90044774 | 6.63 |
| 988 | PM: initial answer - Blue square | Prospective memory | UKBB00000651 | 6.62 |
| 989 | Average diameter for HDL particles | GCST90092828 | 6.62 |
| 990 | wg rh intensity-contrast superiorfrontal | GCST90003854 | 6.62 |
| 991 | Medical abortion | FING00000796 | 6.60 |
| 992 | PALM3 levels | GCST90470153 | 6.58 |
| 993 | Prospective memory result | Prospective memory | UKBB00000713 | 6.58 |
| 994 | CDKN1A/DAB2 ratio | GCST90313967 | 6.58 |
| 995 | IDP dMRI TBSS FA Retrolenticular part of internal capsule L | GCST90003898 | 6.57 |
| 996 | IGFBP7 levels | GCST90469532 | 6.57 |
| 997 | Right ventricular end systolic volume | GCST90268118 | 6.56 |
| 998 | FAM3B/GPA33 ratio | GCST90314778 | 6.56 |
| 999 | Sedentary behavior at work | GCST90104345 | 6.56 |
| 1000 | Mean corpuscular hemoglobin | GCST90002323 | 6.56 |